Company: WCT
Filing Date: 2025-09-09
Form Type: 6-K
Source: 0001213900-25-086185
Chunk: 0

Company: Wellchange Holdings Co Ltd
Filing Date: 2025-09-09
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number: 001-42294

Wellchange Holdings Company Limited

(Translation
of registrant’s name into English)

Unit E, 11/F, Billion Plaza II, 10 Cheung Yue Street

Cheung Sha Wan, Kowloon, Hong Kong
(Address of principal executive office)</div>

Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:

<div align='center'>Form 20-F ☒ Form
40-F ☐</div>

Appointment of Ms. Fang Li Chieh as a Director

On September 5, 2025, the board of directors (“Board”)
of Wellchange Holdings Company Limited (“Company”) appointed Ms. Fang Li Chieh (“Ms. Fang”) as a director of the
Company. Ms. Fang is the founder and Chief Financial Officer of Fortune Pioneer International Co., Ltd., a Taiwan-based computer information
supply and service company established in 2008, and the founder of Inspire Medical Corp., an international trading business for computer
components and related products established in 2021. She completed the Banking and Finance Program at Chinese Culture University in
2020 and holds professional licenses and qualifications in the financial, insurance, real estate, and securities industries, including
certifications as a life and property insurance agent, trust business personnel, securities broker/dealer representative, stock affairs
specialist, senior securities broker/dealer representative, and bond trader/fixed income personnel. With more than a decade of entrepreneurial
experience and broad professional qualifications, Ms. Fang brings significant expertise in corporate finance, capital markets, and business
management to the Board.

Ms. Fang entered into a director offer
letter with the Company on September 5, 2025, pursuant to which she will serve as a director until her successor is duly elected and
qualified, subject to annual re-appointment by the Board. Under the director offer letter, Ms. Fang will receive annual compensation of
US$36,000 for her services as a director of the Company. The director offer letter is qualified